Danish biotech company in protein deal with US company
ExpreS2ion Biotechnologies has made a partnership deal with an American company that could result in millions for the Danish company. The long-term goal is milestone payments and royalties.
The Danish biotech company ExpreS2ion Biotechnologies, a two-year-old spin-off from Affitech, has recently made a partnership deal with a US pharmaceutical company.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Danish protein manufacturer with new US factory
For abonnenter
